Pharma Focus Asia
KP - Sustainable Packaging Solutions

Piramal's Pharma Solution invests $40 million in new technology


Piramal Pharma Solutions plans to invest USD 40 million in new equipment and next generation technologies.


This investments include areas such as Anti-body Drug Conjugation (ADC), Advanced Flow Reactor (ARF) and Biocatalysis Centre of Excellence systems.

In addition to the investment of USD 40 million in new equipment and technologies, they are also augmenting related infrastructure. Recently the company completed a green field facility ($10M) to double its Discovery Services capacity, and also approved a $20M capacity expansion for Hormonal (Morpeth) and ADC (Grangemouth) manufacturing.


Company NamePiramal Pharma Solutions
TypeNew Equipment & Technologies
Estimated Cost$40 million
Latest Issue
Get instant
access to our latest e-book
Standard BioTools™MFA + MMA 2024CPHI Chine || PMEC China 2024Gibco Adherent Kidney Media PanelAsia Healthcare Week 2024CPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024ISPE Singapore Affiliate Conference & Exhibition 2024Rehab Expo 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?